Related references
Note: Only part of the references are listed.Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
D. S. Bakker et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Diagnosis and Management of Conjunctivitis for the Dermatologist
Melinda Gooderham et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Fa-Ping Wang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
Alison D. Treister et al.
JAMA DERMATOLOGY (2018)
IL-25 and CD4+ TH2 cells enhance type 2 innate lymphoid cell-derived IL-13 production, which promotes IgE-mediated experimental food allergy
Jee-Boong Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis
H. FUJISHIMA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Share Paper
